|
LXRX Lexicon Pharmaceuticals Inc 1062822 |
| Balance Sheet |
|
Current Assets
|
$196,577,000.00 |
|
Assets
|
$250,060,000.00 |
|
Current Liabilities
|
$14,706,000.00 |
|
Liabilities
|
$75,535,000.00 |
|
Equity
|
$174,525,000.00 |
|
Shares Out
|
446870629.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-23,922,000.00 |
|
Investing Cash Flow
|
$-86,724,000.00 |
| Market Analysis |
Market Cap
|
$974,177,971.22 |
|
Price
|
$2.18 |
|
BVPS
|
0.39 |
|
PB
|
5.59 |
|
EPS
|
-0.07 |
|
PS
|
192.98 |
|
FCF
|
$-23,922,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:36 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:26 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-0.04 |
|
|
2026-05-07 |
|
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
0.01 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.04 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LXRX documents filed with the SEC.
LXRX Filings
Clear
